The seventh annual BioCap Conference will bring together international investors, companies who are seeking finance and those who have a track record of raising finance. BioCap is the only specialist life science investment and showcase conference in the North of England and is aimed at highlighting the wealth of life science investment opportunities.
Call For Pitches Competition
The conference will continue to host the popular 'Company Pitching' competition and the submission of applications is now open. Applications are invited from companies who are an established biomedical business and seeking or shortly starting to seek funding of £500k or above.
The full conference programme will follow shortly.
In 2017, the following investors attended BioCap:
Acceleris Capital, Alderley Park Ventures, Bamburgh Capital, Brightstart Partners, Capital Enterprise, Capital Cell, Catapult Ventures, Complete Resourcing, Deepbridge Capital LLP, Enterprise Ventures, Epidarex Capital, EV Group, Finance Wales plc, Foresight Group, GM&C Life Sciences Fund, Ignite Capital Partners, Innovate UK, IP Group, Johnson & Johnson Innovation, Kreos Capital, Laidlaw & Company, Liberum, Longbow Capital, London Stock Exchange, Maven, Mercia, Medius Associates, Nasdaq, New Wave Ventures, North West Business Angels, Northstar Ventures, Parkwalk Advisors, Peel Hunt, Pfizer LLC, Syncona Investment Management, Scottish Development International, Shore Capital, Silicon Valley Bank, Spark Impact, Syndicate Room, Synergy Health, Takeda Ventures, Takeda TAKcelerator, Torreya Partners, Touchstone Innovations, WG Partners LLP, Warwick Ventures, WGN.
Premium Member: £125.00 + VAT
Member: £155.00 + VAT
Non-Member: £275.00 + VAT
To discuss the sponsorship and exhibition opportunities available at the conference, please contact Helen Williams at email@example.com or on 07714 168020.